CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-20.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 30, 2026 | Brainin Robert Lawrence · director, officer: CEO | A-Award | 100,000 | $7.80 |
| Jan 30, 2026 | Brainin Robert Lawrence · director, officer: CEO | A-Award | 150,000 | $7.80 |
| Jan 30, 2026 | Brainin Robert Lawrence · director, officer: CEO | A-Award | 62,500 | $7.80 |
| Jan 30, 2026 | Brainin Robert Lawrence · director, officer: CEO | A-Award | 225,000 | $7.80 |
| Jan 30, 2026 | Brainin Robert Lawrence · director | A-Award | 23,030 | $4.64 |
| Jan 30, 2026 | Brainin Robert Lawrence · director | A-Award | 19,070 | $5.51 |
| Jan 30, 2026 | Brainin Robert Lawrence · director | A-Award | 14,130 | $7.00 |
| Jan 30, 2026 | Brainin Robert Lawrence · director | A-Award | 9,901 | $10 |
| Nov 7, 2025 | Breitfeld Philip P. · director | A-Award | 13,790 | $6.80 |
| Nov 7, 2025 | SIDRANSKY DAVID · director | A-Award | 21,216 | $6.80 |
| Nov 7, 2025 | Mendelson Daniel Newman · director | A-Award | 13,790 | $6.80 |
| Nov 7, 2025 | TOBIN SCOTT R · director, 10 percent owner: | A-Award | 25,460 | $6.80 |
| Nov 7, 2025 | ACKERMAN JOEL · director | A-Award | 21,216 | $6.80 |
| Nov 6, 2025 | ACKERMAN JOEL · director | M-Exempt | 94,405 | $2.10 |
| Nov 18, 2024 | Breitfeld Philip P. · director | A-Award | 18,715 | $4.64 |
| Nov 18, 2024 | SIDRANSKY DAVID · director | A-Award | 21,880 | $4.64 |
| Nov 18, 2024 | Mendelson Daniel Newman · director | A-Award | 21,590 | $4.64 |
| Nov 18, 2024 | TOBIN SCOTT R · director, 10 percent owner: | A-Award | 34,550 | $4.64 |
| Nov 18, 2024 | ACKERMAN JOEL · director | A-Award | 43,190 | $4.64 |
| Nov 1, 2024 | ACKERMAN JOEL · director | M-Exempt | 16,667 | $5.43 |
| Nov 1, 2024 | ACKERMAN JOEL · director | M-Exempt | 88,470 | $2.10 |
| Apr 1, 2024 | Davis Brady · officer: President | A-Award | 68,000 | $6.50 |
| Apr 1, 2024 | Davis Brady · officer: President | A-Award | 7,500 | $6.50 |
| Apr 1, 2024 | Davis Brady · officer: President | A-Award | 135,000 | $6.50 |
| Jan 16, 2024 | Mendelson Daniel Newman · director | Purchase | 1,000 | $6.50 |
| Jan 12, 2024 | Mendelson Daniel Newman · director | Purchase | 2,000 | $6.27 |
| Jan 11, 2024 | Mendelson Daniel Newman · director | Purchase | 2,944 | $6.31 |
| Jan 10, 2024 | Mendelson Daniel Newman · director | Purchase | 3,000 | $6.25 |
| Jan 9, 2024 | Mendelson Daniel Newman · director | Purchase | 1,000 | $6.15 |
| Jan 8, 2024 | Mendelson Daniel Newman · director | Purchase | 2,000 | $6.09 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 9Reduced 15Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BATTERY MANAGEMENT CORP. | Unchanged | 2,421,673 | May 15, 2026 |
| Battery Management Corp. | Unchanged | 2,421,673 | Aug 14, 2026 |
| NEA Management Company, LLC | Unchanged | 1,713,720 | Aug 14, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 1,713,720 | May 15, 2026 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | Unchanged | 319,674 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 301,353 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 299,520 | May 15, 2026 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | Reduced | 295,658 | Aug 10, 2026 |
| MORGAN STANLEY | Reduced | 242,300 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 235,400 | Aug 13, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 214,058 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 145,539 | May 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 139,039 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 129,848 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 123,900 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 30, 2026